Takeda Pharmaceutical Company Limited (TAK) Q1 2026 Earnings Call Transcript
· seekingalpha.com
Takeda (TAK) Q1 FY2026 earnings call: core revenue -0.5% CER, pipeline and launch updates
Presentation
Christopher David O'Reilly
Global Head of Investor Relations & Global Finance
[Interpreted] Thank you very much for joining us today despite a v...